Ixazomib citrate (S)-isomer

SL-10769

Ixazomib citrate (S)-isomer, >98%

IUPAC Name : (S)-2,2'-(2-(1-(2-(2,5-Dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is an enantiomer of Ixazomib citrate, which is a second-generation proteasome inhibitor. Ixazomib citrate is used for the treatment of multiple myeloma.

References : Liu R. et al.: Cell Physiol Biochem., 41(2), 451-465, 2017; Chauhan D. et al.: Clin Cancer Res.,17(16), 5311-5321, 2011; Kupperman E. et al.: Cancer Res. 70(5), 1970-1980, 2010.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.